QT延长与Bedaquiline的使用有关,这是一种新的抗结核药物
Nicholas Gavras1, Neil W Schluger
1From the Department of Medicine, New York Medical College, Valhalla, NY.
Cardiology in review
|October 8, 2024
概括
贝达奎林在短短6个月内为多抗药结核病 (MDR-TB) 提供了高治愈率. 临床数据显示,贝达基林的使用是安全的,与心脏事件的增加无关,支持其继续使用.
科学领域:
- 药理学 药理学 是一个学科.
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
背景情况:
- 历史上,多抗药结核病 (MDR-TB) 治疗需要长时间,效果较差的治疗方案.
- 贝达基林是一种二甲基诺林,抑制了腺三酸盐合成酶,提供了更短的治疗选择.
- 人们对贝达基林的心脏安全性,特别是QT延长的安全性表示担忧.
研究的目的:
- 审查已公布的关于贝达基林在MDR-TB治疗中的使用数据.
- 评估贝达奎林与心脏不良事件 (包括QT延长) 之间的关联.
- 评估贝达基林在临床实践中的整体安全性.
主要方法:
- 系统审查关于贝达奎林使用的已发表文献.
- 对报告QT延长和心脏事件的研究分析.
- 包括单疗法和组合疗法方案的数据.
主要成果:
- 含贝达基林的疗法在6个月内可达到MDR-TB治疗率的90%左右.
- 已公布的数据表明,在使用贝达基林时,心脏病死亡或临床显著的心脏事件的数量没有增加.
- 药物在常规临床环境中的安全性似乎令人放心.
结论:
- 贝达基林在治疗MDR-TB方面是有效和安全的,提供了显著更短的治疗持续时间.
- 该审查支持在MDR-TB管理中继续使用贝达基林.
- 有证据表明,对心脏不良事件的担忧在临床实践中没有得到证据.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
102
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
102
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
921
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
921


